Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Learn about the flu shot, COVID-19 vaccine, and our masking policy »
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Get the iPhone MyHealth app »
Get the Android MyHealth app »
Early introduction of HMG-CoA reductase inhibitors could prevent the incidence of transplant coronary artery disease 35th Annual Congress of the Japan-Society-for-Transplantation Kato, T., Tokoro, T., Namii, Y., Kobayashi, T., Hayashi, S., Yokoyama, I., Morimoto, S., Chan, M., Giannetti, N., Hunt, S. A. ELSEVIER SCIENCE INC. 2000: 331–33
View details for Web of Science ID 000085928900029
View details for PubMedID 10715431